Delivery Order SPE2DR25D2206-SPE2DR26F9HD3
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 22, 2025, for the supply of LENVIMA 10 MG daily dose (30-count packages) valued at $10,773.72. This is a firm fixed price delivery order with no set-aside designation, issued under competitive procedures and scheduled for completion by January 14, 2026. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency awarded a $10,773.72 delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Lenvima 18 mg daily dose in a 90-day supply quantity. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The order will be fulfilled from AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Lenvima 8 mg daily dose in quantities of 60 units, with a ceiling value of $10,773.72 and completion targeted for December 22, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a continuation of AmerisourceBergen's critical role as a pharmaceutical distributor supporting federal medical procurement. The award...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 20, 2025, for the supply of Lenvima 10 mg daily dose tablets (30-count units) with a ceiling value of $10,773.72. This is a firm fixed price delivery order with no set-aside designation, representing a competitive award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $21,547.44 by the Defense Logistics Agency (DLA) on November 6, 2025, for the supply of LENVIMA 10 mg daily dose in quantities of 30 units. The contract is a firm fixed price delivery order with no set-aside designation, indicating competitive award through open competition. Performance will be fulfilled from the contractor's Conshohocken, Pennsylvania location, with an ultimate completion date of December 1, 2025. This award...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of LENVIMA 8 mg daily dose tablets (60-count units) under a firm fixed-price contract valued at $21,547.44. This competitively awarded, non-set-aside delivery order has an ultimate completion date of November 26, 2025, and is being fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 26, 2025, for the supply of Lenvima 8 mg daily dose tablets in a quantity of 60 units, valued at $10,773.72. This contract represents a firm fixed-price delivery order with an ultimate completion date of December 18, 2025, and was competitively awarded without set-aside provisions. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency awarded a delivery order valued at $32,321.16 to AmerisourceBergen Drug Corp for the supply of LENVIMA (lenvatinib) 14 mg daily dose in quantities of 60 tablets. This is a firm fixed-price, competitive delivery order with no set-aside designation, issued on December 3, 2025, with an ultimate completion date of December 24, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $10,223.24 to AmerisourceBergen Drug Corp for LENVIMA 14 mg daily dose, 60-count units. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, scheduled for completion by August 5, 2025. The award was issued on July 15, 2025, and the product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $10,223.24 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Lenvima 14 mg daily dose (60-count package), with an ultimate completion date of August 14, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger...
- SPE2DR25D2206Indefinite Delivery Contract
- SPE2DR25D2206-SPE2DR26F9HD3Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 23, 2025, for the supply of LENVIMA 14 mg daily dose medication in 60-count units, with a contract ceiling value of $10,773.72. This firm fixed-price delivery order, with an ultimate completion date of January 15, 2026, represents a non-set-aside, competitively awarded procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, a $999.99 billion comprehensive global pharmaceutical support vehicle running through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement supporting military and veteran healthcare systems. The company's extensive portfolio of federal contract awards with the Defense Logistics Agency encompasses a wide range of pharmaceutical products and medical supplies across multiple therapeutic domains. LENVIMA, a specialty oncology medication, aligns with the company's demonstrated capability to supply brand-name pharmaceuticals and specialized medical commodities essential to support Defense Health Agency and other government healthcare system requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.8k | 12/22/25 |